ALX4 Activators
ALX4 Activators encompasses a diverse range of chemicals that can indirectly influence the expression of ALX4. These chemicals generally act by modulating the activity of various cellular signaling pathways, including the retinoic acid pathway, Wnt signaling, EGF receptor signaling, adenylate cyclase/cAMP/PKA signaling, insulin receptor signaling, protein kinase C signaling, glucocorticoid receptor signaling, mTOR signaling, the MAPK/ERK pathway, and TGF-beta signaling. Each of these pathways can have a distinct impact on ALX4 expression.
For example, retinoic acid activates the retinoic acid receptor, which can indirectly influence ALX4 via transcriptional regulation. Similarly, lithium chloride inhibits GSK3-beta, a kinase involved in Wnt signaling, thereby affecting ALX4 expression indirectly. In contrast, EGF activates the EGF receptor, which can influence the MAPK/ERK pathway and affect ALX4 expression. Other chemicals, such as forskolin, insulin, PMA, dexamethasone, rapamycin, PD98059, Wnt3a, LY294002, and SB431542, act on different cellular pathways to indirectly influence ALX4 expression. While the specific mechanisms and outcomes of these chemical interactions are diverse, they all belong to the class of ALX4 Activators because of their potential influence on ALX4 expression.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can activate the retinoic acid receptor, which can indirectly influence the expression of ALX4 via transcriptional regulation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride can inhibit GSK3-beta, a kinase involved in Wnt signaling, thereby affecting the ALX4 expression indirectly. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can activate adenylate cyclase, influencing cAMP levels and PKA activity, which can indirectly affect ALX4 expression. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin can activate the insulin receptor, affecting PI3K/AKT signaling and potentially influencing ALX4 expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate protein kinase C, which can indirectly influence ALX4 expression via signal transduction pathways. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can bind to the glucocorticoid receptor, which can indirectly influence ALX4 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin can inhibit mTOR signaling, which is a key regulator of cell growth and proliferation, and indirectly affect ALX4 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, a kinase involved in the MAPK/ERK pathway, potentially influencing ALX4 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of PI3K, which can inhibit the PI3K/AKT pathway and indirectly affect ALX4 expression. | ||||||